The demographics of lung cancer change every day. The disease, which directly affects the respiratory system, has long been associated with smokers—but that is rapidly changing. "Before it was rare, ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Next month, 108 colleagues from Bristol Myers Squibb will embark on a taxing journey from Cannon Beach, Ore. to Long Branch, N.J. as part of the 2025 Coast 2 Coast 4 Cancer (C2C4C) ride — nearly a ...

It’s no secret that our efforts to save the planet from the excesses of global trade are failing spectacularly. Our bodies are riddled with manmade compounds, cities are routinely enveloped by massive ...

KNOXVILLE, Tenn. — Lung cancer is the most common and most deadly cancer in Tennessee, but an expansion to the University of Tennessee Medical Center's services is aimed at bringing down those numbers ...

As Tania Rodrigues drove to work one morning in January 2024, something unusual happened with her vision. “All of a sudden, I was looking through a kaleidoscope or perhaps like a fly’s eye,” the ...

New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. In the U.S., ultra-processed foods are everywhere—found ...

A research team has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, opening new possibilities for cancer therapy. This breakthrough addresses the ...

The FDA on Friday granted accelerated approval to zongertinib (Hernexeos) for non-squamous non-small cell lung cancer (NSCLC) patients harboring HER2 tyrosine kinase domain (TKD) activating mutations.